Literature DB >> 24875249

Fabrication of biofunctionalized, cell-laden macroporous 3D PEG hydrogels as bone marrow analogs for the cultivation of human hematopoietic stem and progenitor cells.

Lisa Rödling1, Annamarija Raic, Cornelia Lee-Thedieck.   

Abstract

In vitro proliferation of hematopoietic stem cells (HSCs) is yet an unresolved challenge. Found in the bone marrow, HSCs can undergo self-renewing cell division and thereby multiply. Recapitulation of the bone marrow environment in order to provide the required signals for their expansion is a promising approach.Here, we describe a technique to produce biofunctionalized, macroporous poly(ethylene glycol) diacrylate (PEGDA) hydrogels that mimic the spongy 3D architecture of trabecular bones, which host the red, blood-forming bone marrow. After seeding these scaffolds with cells, they can be used as simplified bone marrow analogs for the cultivation of HSCs. This method can easily be conducted with standard laboratory chemicals and equipment. The 3D hydrogels are produced via salt leaching and biofunctionalization of the material is achieved by co-polymerizing the PEGDA with an RGD peptide. Finally, cell seeding and retrieval are described.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24875249     DOI: 10.1007/7651_2014_84

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Lectin-mediated reversible immobilization of human cells into a glycosylated macroporous protein hydrogel as a cell culture matrix.

Authors:  Nicholas Bodenberger; Dennis Kubiczek; Laura Trösch; Ali Gawanbacht; Susanne Wilhelm; Denis Tielker; Frank Rosenau
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

2.  3D models of the hematopoietic stem cell niche under steady-state and active conditions.

Authors:  Lisa Rödling; Ivo Schwedhelm; Saskia Kraus; Karen Bieback; Jan Hansmann; Cornelia Lee-Thedieck
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.